Contract Research Organizations
•37 stocks
•
Total Market Cap: Loading...
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (37)
| Company | Market Cap | Price |
|---|---|---|
|
TMO
Thermo Fisher Scientific Inc.
Thermo Fisher provides contract research organization services (CRO capabilities) for outsourced drug development.
|
$221.84B |
$585.76
-0.29%
|
|
IQV
IQVIA Holdings Inc.
IQVIA operates as outsourced drug development and clinical research services akin to a CRO.
|
$38.23B |
$227.68
+1.24%
|
|
LH
Labcorp Holdings Inc.
Labcorp functions as aContract Research Organization offering outsourced drug development and regulatory support services.
|
$22.07B |
$265.50
-0.05%
|
|
MEDP
Medpace Holdings, Inc.
Medpace's core business is a specialized full-service CRO delivering Phase I–IV clinical development services.
|
$16.63B |
$616.99
+4.25%
|
|
ICLR
ICON Public Limited Company
Directly describes ICON's outsourced drug development and management services as a Contract Research Organization.
|
$13.59B |
$165.03
+0.29%
|
|
CRL
Charles River Laboratories International, Inc.
CRL operates as a contract research organization, outsourcing preclinical drug development services.
|
$8.25B |
$170.66
+1.80%
|
|
OLED
Universal Display Corporation
Contract research services via Adesis subsidiary.
|
$5.41B |
$113.94
+0.18%
|
|
RXRX
Recursion Pharmaceuticals, Inc.
Collaborations with pharma partners and outsourced discovery work resemble a CRO-type service model.
|
$1.81B |
$4.25
+2.04%
|
|
AZTA
Azenta, Inc.
Genewiz genomic sequencing and broader SMS/Multiomics services align with Contract Research Organizations.
|
$1.60B |
$36.38
+4.27%
|
|
FTRE
Fortrea Holdings Inc.
Fortrea operates as a standalone contract research organization providing outsourced clinical development services.
|
$981.00M |
$11.96
+9.72%
|
|
FLGT
Fulgent Genetics, Inc.
Contract Research Organization services for bioPharma.
|
$918.27M |
$30.55
+1.82%
|
|
DNA
Ginkgo Bioworks Holdings, Inc.
Contract Research Organizations as a historic and current service model.
|
$483.66M |
$8.48
+3.86%
|
|
ABSI
Absci Corporation
Partnership-driven model for drug creation aligns with Contract Research Organizations (CRO)-like outsourced R&D services.
|
$438.10M |
$2.96
+1.02%
|
|
CLPT
ClearPoint Neuro, Inc.
Biologics and drug-delivery consulting capabilities (GLP expansion, preclinical support) align with CRO-like outsourced development services.
|
$392.87M |
$14.28
+3.33%
|
|
QTRX
Quanterix Corporation
Offers contract research services via its Accelerator Lab, aligning with CRO-type activities.
|
$309.46M |
$6.98
+4.80%
|
|
LFCR
Lifecore Biomedical, Inc.
Lifecore's development pipeline and development services align with Contract Research Organizations.
|
$282.87M |
$7.54
-1.31%
|
|
ACRS
Aclaris Therapeutics, Inc.
The company reports contract research revenue, indicating provided drug development services.
|
$271.91M |
$2.69
+7.37%
|
|
IMRX
Immuneering Corporation
The company relies on contract research organizations for preclinical/clinical testing and trials.
|
$265.13M |
$7.36
+0.82%
|
|
MXCT
MaxCyte, Inc.
Contract Research Organizations tag reflects MaxCyte's CRO-like gene editing assessment services through SeQure Dx.
|
$178.03M |
$1.67
-0.30%
|
|
BNR
Burning Rock Biotech Limited
Biopharma services segment indicates outsourced R&D, clinical testing, and development support.
|
$147.10M |
$16.55
+16.14%
|
|
CSBR
Champions Oncology, Inc.
Company provides outsourced drug development and preclinical/clinical research services to biopharma (CRO-style).
|
$93.27M |
$6.52
-3.69%
|
|
FBIO
Fortress Biotech, Inc.
Fortress engages in outsourced development activities and governance across its portfolio, aligning with CRO services.
|
$77.06M |
$2.56
-0.97%
|
|
CBUS
Cibus, Inc.
Reported contract research revenue indicates direct R&D services provided to clients alongside platform licensing.
|
$68.34M |
$1.27
+0.79%
|
|
AKYA
Akoya Biosciences, Inc.
Contract Research Organizations alignment due to outsourced lab services and clinical testing capabilities.
|
$64.26M |
$1.29
|
|
ABVC
ABVC BioPharma, Inc.
BioKey provides Contract Research Organization services, including API characterization, formulation development, and regulatory submissions.
|
$63.33M |
$2.52
-6.51%
|
|
BDSX
Biodesix, Inc.
Biodesix's Development Services revenue aligns with CRO-like outsourced diagnostic testing for partners.
|
$50.08M |
$7.29
+6.73%
|
|
VNRX
VolitionRx Limited
Nu.Q Discover provides epigenetic profiling services to drug developers, akin to Contract Research Organizations.
|
$34.65M |
$0.32
-0.34%
|
|
PLUR
Pluri Inc.
Contract research and development services complement CDMO capabilities and scale the pipeline.
|
$30.99M |
$3.66
-3.68%
|
|
RADX
Radiopharm Theranostics Limited
Company provides external development services for others, akin to CRO activities.
|
$30.04M |
$4.43
-2.53%
|
|
NOTV
Inotiv, Inc.
Inotiv operates as a CRO delivering nonclinical drug discovery and development services, aligning with the Contract Research Organizations tag.
|
$28.25M |
$0.81
-1.84%
|
|
BFRG
Bullfrog AI Holdings, Inc. Common Stock
Engages in external collaborations/partnerships to provide AI-driven drug development services, akin to CRO-type engagements.
|
$8.58M |
$0.86
+1.46%
|
|
SEED
Origin Agritech Limited
Origin provides breeding services and collaborative R&D through a service consortium, aligning with Contract Research Organizations.
|
$7.35M |
$1.26
+8.62%
|
|
APM
Aptorum Group Limited
Aptorum plans near-term revenue from biopharma services via the DiamiR merger, aligning with contract research/Development outsourcing.
|
$7.11M |
$1.33
+2.31%
|
|
BUDZ
WEED, Inc.
Sangre AgroTech represents plant genomic research services, akin to contract research and development.
|
$5.44M |
$0.04
|
|
POAI
Predictive Oncology Inc.
Provides outsourced drug discovery services (wet lab, testing, and preclinical support) akin to a CRO.
|
$4.71M |
$6.37
-1.70%
|
|
YBGJ
Yubo International Biotech Limited
Provides outsourced research/testing services and advisory functions (CRO-like capabilities).
|
$2.46M |
$0.01
|
|
ELAB
PMGC Holdings Inc.
Contract Research Organizations (CRO)-like R&D capabilities through PMGC Research Inc. for biotech development.
|
$2.00M |
$4.66
-1.38%
|
Loading company comparison...
Loading industry trends...
Loading research report...
